Multiple myeloma patient Bob Munro (pictured below) explains what it's like to live with the rare blood cancer and how his diagnosis led him on the journey of a lifetime – cycling from
There should be an independent review of how advances in cancer treatment are valued and paid for by the NHS and healthcare providers, according to a new policy report calling for improveme
Almirall has begun an option agreement with California’s Bioniz, which could see it buy the entire company and its skin cancer and alopecia drug BNZ-1.
US-based Merck & Co has forged an R&D tie-up with Taiho and Astex Pharmaceuticals, focused on developing small molecule drugs targeting the KRAS gene that has become the subject of
Black Diamond Therapeutics has become the first biotech to announce an IPO in 2020, asking investors to fund a clinical trial to test its new approach to tackling cancer.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.